v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2024   131,160,842      
Beginning balance at Dec. 31, 2024 $ 153,149 $ 2 $ 840,358 $ 1 $ (687,212)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation expense 5,681   5,681    
Unrealized (loss) gain on investments during the period, net of tax (16)     (16)  
Net loss (51,890)       (51,890)
Ending balance (in shares) at Mar. 31, 2025   131,160,842      
Ending balance at Mar. 31, 2025 106,924 $ 2 846,039 (15) (739,102)
Beginning balance (in shares) at Dec. 31, 2024   131,160,842      
Beginning balance at Dec. 31, 2024 153,149 $ 2 840,358 1 (687,212)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Unrealized (loss) gain on investments during the period, net of tax (11)        
Net loss (104,481)        
Ending balance (in shares) at Jun. 30, 2025   134,494,438      
Ending balance at Jun. 30, 2025 60,860 $ 2 852,561 (10) (791,693)
Beginning balance (in shares) at Mar. 31, 2025   131,160,842      
Beginning balance at Mar. 31, 2025 106,924 $ 2 846,039 (15) (739,102)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of pre-funded warrants (in shares)   3,199,984      
Issuances of common stock under the employee stock purchase plan (in shares)   133,612      
Issuance of common stock under the employee stock purchase plan 197   197    
Stock-based compensation expense 6,325   6,325    
Unrealized (loss) gain on investments during the period, net of tax 5     5  
Net loss (52,591)       (52,591)
Ending balance (in shares) at Jun. 30, 2025   134,494,438      
Ending balance at Jun. 30, 2025 $ 60,860 $ 2 852,561 (10) (791,693)
Beginning balance (in shares) at Dec. 31, 2025 180,514,014 180,514,014      
Beginning balance at Dec. 31, 2025 $ 120,868 $ 2 1,009,138 82 (888,354)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options (in shares)   101,500      
Issuance of common stock upon exercise of stock options 393   393    
Stock-based compensation expense 4,644   4,644    
Unrealized (loss) gain on investments during the period, net of tax (83)     (83)  
Net loss (49,122)       (49,122)
Ending balance (in shares) at Mar. 31, 2026   180,615,514      
Ending balance at Mar. 31, 2026 $ 76,700 $ 2 1,014,175 (1) (937,476)
Beginning balance (in shares) at Dec. 31, 2025 180,514,014 180,514,014      
Beginning balance at Dec. 31, 2025 $ 120,868 $ 2 1,009,138 82 (888,354)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options (in shares) 111,424        
Unrealized (loss) gain on investments during the period, net of tax $ (91)        
Net loss $ (91,231)        
Ending balance (in shares) at Jun. 30, 2026 180,737,548 180,737,548      
Ending balance at Jun. 30, 2026 $ 39,809 $ 2 1,019,401 (9) (979,585)
Beginning balance (in shares) at Mar. 31, 2026   180,615,514      
Beginning balance at Mar. 31, 2026 76,700 $ 2 1,014,175 (1) (937,476)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuances of common stock under the employee stock purchase plan (in shares)   112,110      
Issuance of common stock under the employee stock purchase plan 338   338    
Issuance of common stock upon exercise of stock options (in shares)   9,924      
Issuance of common stock upon exercise of stock options 23   23    
Stock-based compensation expense 4,865   4,865    
Unrealized (loss) gain on investments during the period, net of tax (8)     (8)  
Net loss $ (42,109)       (42,109)
Ending balance (in shares) at Jun. 30, 2026 180,737,548 180,737,548      
Ending balance at Jun. 30, 2026 $ 39,809 $ 2 $ 1,019,401 $ (9) $ (979,585)